Dupilumab Injection ( DrugBank: Dupilumab )


1 disease
IDDisease name (Link within this page)Number of trials
160Congenital ichthyosis1

160. Congenital ichthyosis


Clinical trials : 36 Drugs : 72 - (DrugBank : 21) / Drug target genes : 18 - Drug target pathways : 111
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04996485
(ClinicalTrials.gov)
March 1, 202121/7/2021Scientific Substantiation and Assessment of the Effectiveness of Pathogenetic Methods of Therapy for Congenital Ichthyosis in ChildrenScientific Substantiation and Assessment of the Effectiveness of Pathogenetic Methods of Therapy for Congenital Ichthyosis in ChildrenCongenital IchthyosisDrug: Secukinumab Injection;Drug: Ustekinumab Injection;Drug: Dupilumab Injection;Other: Symptomatic therapyNational Medical Research Center for Children's Health, Russian FederationNULLRecruiting6 Months18 YearsAll50Phase 4Russian Federation